Inas Abd-Elsalam

Inas Abd-Elsalam at Cleveland Clinic leads a multidisciplinary irAE management program integrating oncology with subspecialty expertise. She has developed protocols for safe re-challenge with checkpoint inhibitors after serious adverse events, balancing recurrence risk with antitumor benefit. Her work informs clinical decision-making around immunotherapy re-initiation and long-term toxicity monitoring.